Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 9914 | 1044 | 27.9 | 70% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 540 | 13989 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANTOFLOXACIN HYDROCHLORIDE | Author keyword | 8 | 100% | 0% | 5 |
| 2 | SKELETAL TOXICITY | Author keyword | 6 | 80% | 0% | 4 |
| 3 | ANTOFLOXACIN | Author keyword | 6 | 71% | 0% | 5 |
| 4 | QUINOLONE INDUCED ARTHROPATHY | Author keyword | 6 | 100% | 0% | 4 |
| 5 | DR 3355 | Author keyword | 5 | 54% | 1% | 7 |
| 6 | CAS 91524 15 1 | Author keyword | 3 | 100% | 0% | 3 |
| 7 | QUINOLONE ANTIBACTERIAL | Author keyword | 3 | 100% | 0% | 3 |
| 8 | CAS 100986 85 4 | Author keyword | 3 | 40% | 1% | 6 |
| 9 | NEEMAN ICIC | Address | 3 | 60% | 0% | 3 |
| 10 | CHONDROTOXICITY | Author keyword | 3 | 30% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTOFLOXACIN HYDROCHLORIDE | 8 | 100% | 0% | 5 | Search ANTOFLOXACIN+HYDROCHLORIDE | Search ANTOFLOXACIN+HYDROCHLORIDE |
| 2 | SKELETAL TOXICITY | 6 | 80% | 0% | 4 | Search SKELETAL+TOXICITY | Search SKELETAL+TOXICITY |
| 3 | ANTOFLOXACIN | 6 | 71% | 0% | 5 | Search ANTOFLOXACIN | Search ANTOFLOXACIN |
| 4 | QUINOLONE INDUCED ARTHROPATHY | 6 | 100% | 0% | 4 | Search QUINOLONE+INDUCED+ARTHROPATHY | Search QUINOLONE+INDUCED+ARTHROPATHY |
| 5 | DR 3355 | 5 | 54% | 1% | 7 | Search DR+3355 | Search DR+3355 |
| 6 | CAS 91524 15 1 | 3 | 100% | 0% | 3 | Search CAS+91524+15+1 | Search CAS+91524+15+1 |
| 7 | QUINOLONE ANTIBACTERIAL | 3 | 100% | 0% | 3 | Search QUINOLONE+ANTIBACTERIAL | Search QUINOLONE+ANTIBACTERIAL |
| 8 | CAS 100986 85 4 | 3 | 40% | 1% | 6 | Search CAS+100986+85+4 | Search CAS+100986+85+4 |
| 9 | CHONDROTOXICITY | 3 | 30% | 1% | 7 | Search CHONDROTOXICITY | Search CHONDROTOXICITY |
| 10 | BIPHENYLACETIC ACID | 2 | 44% | 0% | 4 | Search BIPHENYLACETIC+ACID | Search BIPHENYLACETIC+ACID |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INDUCED ARTHROPATHY | 53 | 85% | 3% | 28 |
| 2 | QUINOLONE INDUCED ARTHROPATHY | 38 | 78% | 2% | 25 |
| 3 | DRUG INDUCED ARTHROPATHY | 26 | 100% | 1% | 11 |
| 4 | INDUCED TENDINOPATHY | 22 | 81% | 1% | 13 |
| 5 | FLUOROQUINOLONE INDUCED TENDINOPATHY | 17 | 75% | 1% | 12 |
| 6 | RESISTANT HYPOGLYCEMIA | 17 | 100% | 1% | 8 |
| 7 | GATIFLOXACIN THERAPY | 12 | 86% | 1% | 6 |
| 8 | FENBUFEN | 10 | 50% | 1% | 15 |
| 9 | PEDIATRIC CYSTIC FIBROSIS | 9 | 64% | 1% | 9 |
| 10 | AMINOBUTYRIC ACID BINDING | 9 | 59% | 1% | 10 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Appropriate use of fluoroquinolones in children | 2015 | 2 | 41 | 56% |
| Safety issues and drug-drug interactions with commonly used quinolones | 2015 | 1 | 76 | 47% |
| Quinolones Review of Psychiatric and Neurological Adverse Reactions | 2011 | 29 | 68 | 74% |
| Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data | 2009 | 21 | 38 | 74% |
| Quinolone arthropathy in animals versus children | 1997 | 110 | 71 | 72% |
| Risks associated with the therapeutic use of fluoroquinolones | 2013 | 10 | 45 | 53% |
| Tendon Injury and Fluoroquinolone Use: A Systematic Review | 2013 | 6 | 29 | 76% |
| Ciprofloxacin safety in paediatrics: a systematic review | 2011 | 24 | 87 | 55% |
| Fluoroquinolone toxicity profiles: A review focusing on newer agents | 1999 | 216 | 66 | 42% |
| Safety Profile of the Fluoroquinolones Focus on Levofloxacin | 2010 | 34 | 84 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEEMAN ICIC | 3 | 60% | 0.3% | 3 |
| 2 | CITY HOSP BERLIN H HECKESHORN | 1 | 100% | 0.2% | 2 |
| 3 | EDUC SD GIRLS | 1 | 100% | 0.2% | 2 |
| 4 | EPIDEMIOL BIOSTAT INTERNAL MED | 1 | 50% | 0.2% | 2 |
| 5 | EQUIPE SOMMEIL ATTENT PIRAT | 1 | 50% | 0.2% | 2 |
| 6 | PEDIAT PHARMACOL PHARMACOGENETINSERM CIC9 | 1 | 100% | 0.2% | 2 |
| 7 | ATENC PEDIAT | 1 | 27% | 0.3% | 3 |
| 8 | THER EUT EVALUAT UNIT | 1 | 27% | 0.3% | 3 |
| 9 | CHEST INTENS CARE MED | 1 | 50% | 0.1% | 1 |
| 10 | CLIN MED VET PHARMACOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000190907 | EQUIPE ACCUEIL EA 3105//ESCHERICHIA COLI WP2UVRA PKM101//DIRECC INVEST ENSENANZA |
| 2 | 0.0000178032 | LB20304//AT 4140//TEMAFLOXACIN |
| 3 | 0.0000162088 | RUFLOXACIN//ONCE A DAY ADMINISTRATION//RUFLOXACIN HYDROCHLORIDE |
| 4 | 0.0000154161 | HOIGNES SYNDROME//EEG THRESHOLD//EPILEPTOGENIC ACTIVITY |
| 5 | 0.0000116884 | GEMIFLOXACIN//GEMIFLOXACIN MESYLATE//GARENOXACIN |
| 6 | 0.0000106641 | MARBOFLOXACIN//ENROFLOXACIN//DANOFLOXACIN |
| 7 | 0.0000074415 | CLONIC CONVULSION//INDUCED SEIZURES//BEMEGRIDE |
| 8 | 0.0000071936 | INTERACTION WITH CALF THYMUS DNA//COMPETITIVE STUDIES WITH ETHIDIUM BROMIDE//NORFLOXACIN |
| 9 | 0.0000065919 | N SUBSTITUTED PIPERAZINYL QUINOLONES//PIPERAZINYL QUINOLONES//S ENOKI 3394 |
| 10 | 0.0000051109 | TORSADES DE POINTES//TORSADE DE POINTES//ELECT ENGN CYBERNET |